BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
BBOT
32 hedge funds and large institutions have $173M invested in BridgeBio Oncology Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+1
Holders Change %
+3.23%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WP
26
Woodline Partners
San Francisco,
California
| $1.08M | – | – | – |
|
|
MCM
27
Moore Capital Management
New York
| $1.05M | – | – | – |
|
28
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $520K | +$520K | +49,500 | New |
|
29
UBS Group
Zurich,
Switzerland
| $367K | +$367K | +34,927 | +166,319% |
|
|
GAM
30
Gritstone Asset Management
Bethesda,
Maryland
| $259K | +$259K | +24,666 | New |
|
31
Geode Capital Management
Boston,
Massachusetts
| $139K | +$25.3K | +2,405 | +22% |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| $10 | +$10 | +1 | New |
|
|
SSA
33
Schonfeld Strategic Advisors
New York
| – | -$1.25M | -119,880 | Closed |
|
|
CAC
34
Cowen and Company
New York
| – | -$471K | -45,048 | Closed |
|
35
JPMorgan Chase & Co
New York
| – | -$42 | -4 | Closed |
|